Nuclear Safeguards Bill — House of Commons, 2017-10-16
Topic: International Affairs
Patricia Gibson (Scottish National Party, Centre-left): Thank you, Madam Deputy Speaker I am pleased to be speaking in this debate. Once again, we are in a debate where we are all promised a post-Brexit world that is shinier, better and newer than anything we have witnessed up to this point. Whether we are talking about nuclear safeguards, food safety standards, consumer rights, trade with the EU, the strength of the pound, UK nationals living abroad, EU nationals living in the UK, or 30% being wiped off the bond yields leaving a £1.8 trillion black hole in our public sector pensions bill, we are told that it will be all right on the night and that everything will be wonderful The fact is that no state has ever left Euratom before. Despite what we have heard in the Chamber today, some legal experts—I know that we do not always like listening to experts—believe that it would be perfectly possible for the United Kingdom to leave the EU and remain a member of Euratom because, despite sharing the institutions, the two treaties are distinct and have separate legal instruments. I urge the Minister to explore that. The nuclear industry certainly believes that the UK should pursue some form of continuing membership of Euratom. We do not know what form that will take. We have no details or certainty. I think I probably speak for a large chunk of the public across the United Kingdom when I say that the UK Government’s negotiating skills have not inspired confidence I remember sitting in a Committee and being told by the right hon. Member for South Northamptonshire (Andrea Leadsom), who is now the Leader of the House, that it was necessary and, indeed, essential for us to fly nuclear materials across UK skies so that they could be used in a range of medical treatments at the height of their efficacy. Experts now tell us that leaving Europe’s nuclear regulator will put patients in the UK at risk of losing access to vital medical treatments, but those concerns have been dismissed by Conservative Members,. Despite what we have heard tonight, withdrawal from Euratom as part of Brexit would make it harder for the UK to access the nuclear isotopes used in cancer treatments and medical imaging. It is not me who is saying this—I confess that I do not have the medical or scientific expertise to do so—but the Royal College of Radiologists has told us that this is the case, as has Martin McKee, professor of European public health at the London School of Hygiene and Tropical Medicine I could give the House 20 other examples of people at the top of their game who have told us this, but I fear that I lack the time to do so. Despite all that, those concerns were utterly dismissed by the right hon. Member for Chingford and Woodford Green (Mr Duncan Smith), who is no longer in his place, and the Secretary of State told us that these matters are not within the scope of the Bill. I fear that such a response is not reassuring. I am also alarmed, as I am sure many others will be, that someone who is qualified as an economist sees fit to contradict medical experts. Euratom is responsible for co-ordinating and regulating the transport, use and disposal of nuclear materials in Europe, including many of the isotopes used in radiotherapy and some kinds of body scans. It seems that some of the most widely used medical isotopes can be produced only in specialised reactors, none of which is located in the United Kingdom. The materials currently used in Britain are mostly manufactured in the Netherlands, Belgium and France. Experts have told us that there is "no excuse" for Government Ministers failing to foresee the problems that leaving Euratom would cause. They have also indicated, given that all these matters are subject to negotiation, that although it might be possible for the UK to remain within the existing arrangements, it would be "exceptionally complicated" and that the UK’s position would "inevitably be weakened". Those are the words of medical experts at the top of their field. Crucially, no real clarity on how any agreement might be achieved by the UK Government has been forthcoming. The Government’s position paper on Euratom published in July contained little detail even on nuclear power and it did not mention medical isotopes. Perhaps the Minister would care to mention them today. Can he also tell us whether the Secretary of State for Health has been consulted on this matter Ministers have absolutely no excuse for failing to anticipate this controversy. The problems were clearly highlighted in an article in the Financial Times way back in February and in briefings by nuclear industry experts. I know that we do not like experts, but occasionally it is useful to listen to them. As with all aspects of Brexit, there is little evidence of any serious planning.